Team |
Vikas Sinha
Vikas Sinha

Vikas Sinha

Chief Financial Officer, ElevateBio, President & Chief Financial Officer, Allovir

Vikas has more than 25 years of experience in executive finance roles at life sciences companies. He is CFO of ElevateBio and President and CFO of AlloVir, an ElevateBio portfolio company.

Previously, Vikas spent 11 years as CFO of Alexion Pharmaceuticals, where he was responsible for finance, business development, strategy, and information technology. Before joining Alexion, he held positions with Bayer AG in the United States, Japan, Germany, and Canada, including Vice President and CFO of Bayer Pharmaceuticals Corporation in the United States and Vice President and CFO of Bayer Yakuhin Ltd. in Japan. 

Vikas is currently on the board of directors at Verona Pharma. He received his MBA from the Asian Institute of Management, Manila, Philippines, and is a Chartered Accountant, an associate member of the Institute of Chartered Accountants of India, and a Certified Public Accountant in the United States.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.